BridgeBio Pharma - 53 Year Dividend History | BBIO
Historical dividend payout and yield for BridgeBio Pharma (BBIO) since 1971. The current TTM dividend payout for BridgeBio Pharma (BBIO) as of October 31, 2024 is $0.00. The current dividend yield for BridgeBio Pharma as of October 31, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$4.791B |
$0.009B |
|
BridgeBio Pharma Inc. discovers, develops and innovates drugs for genetic diseases. The Company's product platform consists of Mendelian, Oncology and Gene therapy. Its product pipeline includes BBP-265, BBP-831, BBP-631 and BBP-454 which are in clinical stage. BridgeBio Pharma Inc. is based in CA, United States.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
